Display options
Share it on

Ann Thorac Med. 2020 Jul-Sep;15(3):151-154. doi: 10.4103/atm.ATM_165_20. Epub 2020 Jun 18.

The relationship between diagnostic value of chest computed tomography imaging and symptom duration in COVID infection.

Annals of thoracic medicine

Aydın Kant, Uğur Kostakoğlu, Serhat Atalar, Şükrü Erensoy, Tolgahan Sevimli, Barış Ertunç, Enes Dalmanoğlu, İsmail Yılmaz, Ayşe Ertürk, Gürdal Yilmaz

Affiliations

  1. Department of Chest Diseases, Trabzon Vakf?kebir State Hospital, Trabzon, Turkey.
  2. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
  3. Department of Infection Diseases and Clinical Microbiology, Niksar State Hospital, Tokat, Turkey.
  4. Department of Infection Diseases and Clinical Microbiology, Yavuz Selim Bone Diseases and Rehabilitation Hospital, Trabzon, Turkey.
  5. Department of Internal Medicine, Trabzon Vakf?kebir State Hospital, Trabzon, Turkey.
  6. Department of Infection Diseases and Clinical Microbiology, Akçaabat Haçkal? baba State Hospital, Trabzon, Turkey.
  7. Chest Diseases, Akçaabat Haçkal? baba State Hospital, Trabzon, Turkey.
  8. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.

PMID: 32831937 PMCID: PMC7423197 DOI: 10.4103/atm.ATM_165_20

Abstract

OBJECTIVES: Severe acute respiratory syndrome-coronovirus-2 is a global public health problem, in which early diagnosis is required to prevent the spread of infection. In this study, we aimed to reveal the diagnostic value of chest computed tomography (CT) imaging with respect to symptom duration.

METHODS: This retrospective study involved patients from five centers, who were admitted with typical COVID-19 symptoms and found to be positive for COVID-19 real-time reverse transcription-polymerase chain reaction (rtRT-PCR) test.

RESULTS: One hundred and five patients with positive COVID-19 rtRT-PCR test were involved in the study. Sixty percent of these patients had chest CT imaging findings consistent with COVID-19 pneumonia. The most common chest CT finding was bilateral and subpleural ground-glass opacity in middle-lower lobes of the lungs. Chest CT findings were detected in 85.1% of the patients with a symptom duration of more than 2 days. In receiver operating characteristic analysis of this parameter, area under the curve (AUC) was 0.869, while sensitivity and specificity were 90.5% and 76.2%, respectively. It was notable that chest CT findings were 7.17 times more common among the patients aged 60 years and older, with AUC, specificity, and positive predictive value of 0.768, 88.1%, and 84.8%, respectively.

CONCLUSION: Chest CT imaging is a quite valuable tool in patients with longer than 2 days' duration of symptoms, in whom clinical and epidemiological data support the diagnosis of COVID-19 infection. We suggest that the diagnosis of COVID-19 pneumonia should be made with chest CT imaging when rtRT-PCR test cannot be performed or gives a negative result, which is important for public health and to prevent the spread of infection.

Copyright: © 2020 Annals of Thoracic Medicine.

Keywords: COVID-19; Chest computed tomography; symptom duration

Conflict of interest statement

There are no conflicts of interest.

References

  1. Clin Chim Acta. 2020 Jul;506:172-175 - PubMed
  2. Euro Surveill. 2020 Jan;25(3): - PubMed
  3. Clin Chim Acta. 2020 Jun;505:172-175 - PubMed
  4. Emerg Microbes Infect. 2020 Dec;9(1):787-793 - PubMed
  5. Radiology. 2020 Jun;295(3):200463 - PubMed
  6. Lancet Respir Med. 2020 May;8(5):438-440 - PubMed
  7. Int J Antimicrob Agents. 2020 May;55(5):105955 - PubMed
  8. Korean J Radiol. 2020 Apr;21(4):494-500 - PubMed
  9. Radiology. 2020 Jun;295(3):715-721 - PubMed
  10. Radiology. 2020 Aug;296(2):E41-E45 - PubMed

Publication Types